Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q4 FY22 results · Jan–Mar 2022
Wockhardt reported revenue from operations of ₹655.00 crore (up 3.6% from Q4 FY21) and net loss of ₹311.00 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 655.00 | 631.96 | +3.6% | 853.89 | −23.3% |
| Other income | 14.00 | 7.54 | +85.7% | 2.05 | +582.9% |
| Total income | 669.00 | 639.50 | +4.6% | 855.94 | −21.8% |
| Profit before tax | (347.00) | (178.18) | Loss widened | (28.56) | Loss widened |
| Net profit for the period | (311.00) | (106.84) | Loss widened | 1.77 | Turned loss |
| Attributable to shareholders of the company | (258.00) | (92.79) | Loss widened | (6.78) | Loss widened |
| EPS, basic (₹) | (21.20) | (8.38) | not comparable | (0.61) | not comparable |
| Net margin (%) | -47.5 | -16.9 | 0.2 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 474.00 | 261.75 | +81.1% | 308.61 | +53.6% |
| Other income | 22.00 | 6.31 | +248.7% | 3.01 | +630.9% |
| Total income | 496.00 | 268.06 | +85.0% | 311.62 | +59.2% |
| Profit before tax | 87.00 | (113.24) | Turned profit | (103.99) | Turned profit |
| Net profit for the period | 40.00 | (47.05) | Turned profit | (67.12) | Turned profit |
| EPS, basic (₹) | 3.24 | (4.25) | not comparable | (6.06) | not comparable |
| Net margin (%) | 8.4 | -18.0 | -21.7 |
Consolidated
- Filed with BSE
- 31 May 2022, 18:54 IST
- Board meeting
- 30 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 May 2022, 18:54 IST
- Board meeting
- 30 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE